Stay updated with breaking news from Segments Profiled. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
During the forecast period 2023 to 2033, the Secondary Myelofibrosis Therapeutics Market is expected to grow at a value of 6.3% CAGR, according to Future Market Insights. By the year 2033, the global market for Secondary myelofibrosis therapeutics is expected to rise up to a market valuation of US$ 2.74 Billion. Gro...
The global paediatric obesity management market is anticipated to reach a market value of US$ 3.2 billion in 2023 and to reach US$ 4.74 billion by registering a CAGR of 4% from 2023 to 2033. From 2018 to 2022, the market for paediatric obesity management experienced a 3% CAGR.The global prevalence of pediatric obesi...
During the forecast period 2023 to 2033, the Salivary Gland Infection Treatment Market is expected to grow at a value of 9.3% CAGR, according to Future Market Insights. By the year 2033, the global market for Salivary gland infection treatment is expected to rise up to a market valuation of US$ 12,300 Million. Growt...
Between 2022 and 2032, the global multiple endocrine neoplasia market is expected to develop at a high CAGR of over 6.0%. The key force driving the worldwide multiple endocrine neoplasia market is rising consumption of multiple endocrine neoplasia drugs to alleviate symptoms and improve quality of life.Multiple endo...
According to a recent study published by Future Market Insights, the market for Oncolytic Virus Cancer Therapy is forecast to reach a valuation of US$ 22.86 Million by 2023-end, and will eventually reach US$ 250 Million by 2033, growing at an astronomical CAGR of 27%. Governments in various emerging economies have c...